Showing results (371-380 of 485) with videos related to
Sort By:
Pageof 49
BJUI Compass|August 11, 2022
Prognostic differences among Grade Group 4 subgroups in robotic-assisted radical prostatectomyTakeshi Sasaki, Shin Ebara, Tomoyuki Tatenuma, et al.The Journal of Experimental Medicine|December 21, 2006
IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responsesMichishige Harada, Kumiko Magara-Koyanagi, Hiroshi Watarai, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2018
Macrophages Switch Their Phenotype by Regulating Maf Expression during Different Phases of InflammationKenta Kikuchi, Mayumi Iida, Naoki Ikeda, et al.Clinical Genitourinary Cancer|June 30, 2022
Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)Yusuke Sugino, Takeshi Sasaki, Shin Ebara, et al.Cancers|December 11, 2022
Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group)Sanae Namiki, Makoto Kawase, Shin Ebara, et al.Journal of Clinical Medicine|December 23, 2023
The Negative Impact of Inflammation-Related Parameters in Prostate Cancer after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group)Kazumasa Murase, Makoto Kawase, Shin Ebara, et al.International Journal of Clinical Oncology|August 20, 2025
Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in JapanToshiki Anami, Takanobu Motoshima, Yuto Matsushita, et al.Urologic Oncology|May 13, 2022
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunctionYuki Kita, Katsuhiro Ito, Sohei Kanda, et al.Diagnostics (Basel, Switzerland)|October 27, 2022
A Nomogram for Predicting Prostate Cancer with Lymph Node Involvement in Robot-Assisted Radical Prostatectomy Era: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)Makoto Kawase, Shin Ebara, Tomoyuki Tatenuma, et al.International Urology and Nephrology|November 8, 2024
Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group)Yuki Yokoyama, Makoto Kawase, Shin Ebara, et al.Pageof 49